Answers are grounded in this paper and cite their sources.
How would the press, politicians, and funding agencies react to evidence that a new vaccination strategy reduced human immunodeficiency virus (HIV) transmission by 75%, required only a single priming dose and no boosters, was expected to be active against diverse HIV strains, and could be made available immediately at minimal cost? We would expect a flurry of press attention and editorial comment and calls for an emergency program to implement the strategy in the shortest possible time. Such a report was recently published by Lavreys et al. [1], but the “vaccination strategy” was not an injection but male circumcision. In this prospective cohort study, uncircumcised status was an independent risk factor for HIV transmission (hazard rate ratio, 4.0) in a multivariate analysis that controlled for confounding demographic and behavioral factors. However, this important and well-designed study, which overcame major limitations of previous studies, has thus far sparked little notice. In this it is similar to previous studies of circumcision and transmission of HIV/sexually transmitted disease, most of which, although less rigorously controlled and mostly retrospective, reached similar conclusions. Lavreys et al. [1] convincingly argue that the accumulated epidemiologic evidence and the biologic plausibility are strong enough to justify implementation of the strategy now, pending more data on acceptability. For those who remain unconvinced, a randomized controlled trial of adult circumcision is entirely feasible and could be rapidly undertaken by skeptics. It is worth asking, however, why this promising strategy has been investigated at such a leisurely pace (as pointed out by Lavreys et al., 150 years and counting) and why, even now, it has failed to capture the imagination or enthusiasm of more than a handful of investigators. Understanding the factors that have obstructed attention to this potential opportunity may allow us to develop this and other inadequately explored preventive options more effectively in the future. Possible explanations include the low-tech and decidedly nonnovel nature of the intervention; distaste for the procedure; the momentum of a decades-long swing of pediatrician and parent opinion away from circumcision as a painful procedure with insufficient documented medical benefits; a perceived inconsistency in the promotion or even the study of male circumcision, while decrying female “circumcision” (actually clitorectomy); the false assumption that implementation would necessarily require neonatal circumcision and, thus, would take decades to accrue a benefit; and the unproven assumption that attitudes toward circumcision are immutable consequences of religion and culture. Neglecting pursuit of this opportunity on the basis of any of these reasons is unscientific and regrettable. HIV-prevention efforts have been largely directed toward promotion of condoms and the search for a vaccine. After nearly 2 decades, a vaccine still appears to be far off, and, although condoms are an important tool for HIV prevention, the epidemic has nonetheless continued its steady expansion. The enormous benefits of a vaccine, should one prove feasible, and the proven efficacy of condoms, when people are willing to use them, should not blind us to opportunities to explore and implement alternative means of HIV prevention.
No takes yet. Share an insight, caveat, or question.
Thomas R. Moench (2000) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: